FDA Approved: EFAVIRENZ — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Efavirenz (generic) from Cipla USA Inc. under ANDA 204766.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

SUPPL AP for EFAVIRENZ (EFAVIRENZ)